Cardinal Healthcare recalls HydrALAZINE Hydrochloride Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
- Products
-
- HydrALAZINE Hydrochloride Tablets
- Company
- Cardinal Healthcare
- Where it was sold
-
Nationwide USA
Nationwide
- Units affected
- 2 units
- About this recall
- HydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816. NDC: 23155-002-01